European Journal of Heart Failure

NOVEMBER 3, 2024

Development and validation of a machine-learning approach to identify diabetic cardiomyopathy. Aims Abnormalities in specific echocardiographic parameters and cardiac biomarkers have been reported among individuals with diabetes. The high-risk DbCM phenotype was identified based on the incidence of HF on follow-up.

Cardiomyopathy 40

Cardiomyopathy Diabetes Biomarkers Atherosclerosis 40

Cardiometabolic Health Congress

JULY 25, 2024

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. The robust conference agenda begins with FDA updates and advancements in cardiorenal metabolic care.

Education 100

Education Innovation Risk Factors Obesity 100

Heart BMJ

APRIL 15, 2024

This study sought to evaluate the prevalence of cardiovascular risk factors, overt cardiovascular disease and cardiac imaging abnormalities using cardiac magnetic resonance (CMR), in participants with normal LVEF on completion of trastuzumab±anthracycline therapy at least 5 years previously. years (range 5.9–10.8

Cancer 52

Cancer Risk Factors Biomarkers Cholesterol 52

Cardiometabolic Health Congress

OCTOBER 25, 2024

He discussed therapeutic options not only for treating atherosclerosis but also for preventing cardiovascular disease. Attendees dove into cutting-edge topics, including FDA updates, resistant hypertension, and cardiac biomarkers. “I Florez, MD, PhD , explored the future of precision medicine in diabetes.

CME 64

CME Innovation Education Atherosclerosis 64

Circulation: Cardiovascular Quality & Outcomes

OCTOBER 20, 2023

BACKGROUND:The relationship between marijuana use and cardiovascular health remains uncertain, with several observational studies suggesting a potential association with increased adverse atherosclerotic cardiovascular disease (ASCVD) outcomes. P=0.13; 82% versus 75%,P=0.95), diabetes (4.8% were current users. P=0.76; 79.8%

Risk Factors 40

Risk Factors Cardiovascular Disease Cholesterol Biomarkers 40

Stroke Journal

FEBRUARY 1, 2024

Participants with LVI were more likely to have diabetes, tobacco use, and atrial fibrillation (24% versus 14%, p<0.001). There was no significant difference in history of cardiovascular disease events (6% versus 4%, p=0.143). Further studies are needed to validate these CMR biomarkers of stroke risk.

Atherosclerosis 40

Atherosclerosis Stroke Strokes Atrial Fibrillation 40

Dr. Paddy Barrett

OCTOBER 31, 2023

In my experience, some patients present later in life with a significantly elevated Lp(a) but have no evidence of coronary artery disease. They have the biomarker of risk but no evidence of the disease , even later in life when you would expect them to have it. This is the case with an elevated Lp(a). Atherosclerosis.

Coronary Artery Disease 52

Coronary Artery Disease Heart Disease Atherosclerosis Cardiovascular Disease 52

Dr. Paddy Barrett

FEBRUARY 21, 2025

The reason excess weight is such big issues are the health consequences it confers with increased rates of diabetes, heart disease, osteoarthritis, obstructive sleep apnea, non-alcoholic fatty liver disease and others, just to name a few. Avoiding diabetes and its precursor states inclduing insulin resistance is key.

Obesity 81

Obesity Diabetes Cardiovascular Disease Chronic Disease 81

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

DAIC

FEBRUARY 1, 2024

February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country embark on American Heart Month, DAIC has compiled a snapshot of significant cardiovascular disease (CVD) and stroke statistics, along with a review of the atherosclerosis drug market. per 1,000* - 122.4

Cardiovascular Disease 104

Cardiovascular Disease Atherosclerosis Stroke Strokes 104

DAIC

JANUARY 30, 2024

Clinicians currently use two separate risk models to assess patients’ chances of having heart attacks , strokes , and other major cardiovascular events. Clinicians currently use two separate risk models to assess patients’ chances of having heart attacks , strokes , and other major cardiovascular events.

Cardiovascular Disease 52

Cardiovascular Disease Research Heart Attack Heart attacks 52

Cardiometabolic Health Congress

AUGUST 8, 2024

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. Key contributions: Advanced cardiac imaging (e.g., high-sensitivity troponin, NT-proBNP) in risk stratification Utilization of advanced echocardiographic techniques (e.g.,

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Dr. Paddy Barrett

APRIL 26, 2024

On the far end of that line is type two diabetes. Insulin resistance and diabetes may not ‘ cause ’ coronary artery disease, but they are huge accelerants. Compared to someone without type 2 diabetes, the person with type 2 diabetes has a risk that is tenfold higher 1. Let me be 100% clear, however.

Heart Disease 105

Heart Disease Coronary Artery Disease Diabetes Genetic predisposition 105

Dr. Paddy Barrett

APRIL 12, 2024

Similar patterns have been observed for cardiovascular disease and also cancer. Less major diseases earlier in life. Less gastroesophageal reflux disease. Less diabetes. 2 [link] 3 Physical activity patterns and biomarkers of cardiovascular disease risk in hunter-gatherers. More movement.

Quality of Life 125

Quality of Life Blood Pressure Exercise Chronic Disease 125

Dr. Paddy Barrett

SEPTEMBER 13, 2024

Insulin resistance is a major risk factor for the leading causes of death, the leading one being cardiovascular disease. Everyone sits somewhere on the scale of insulin sensitivity from very insulin sensitive to very insulin resistant at the point of type 2 diabetes. Measuring Insulin Resistance. Some complex. Some simple.

Risk Factors 106

Risk Factors Heart Disease Dementia Diabetes 106

European Journal of Heart Failure

FEBRUARY 12, 2024

Left ventricular (LV) global longitudinal strain (GLS) assessed via feature tracking cardiac magnetic resonance imaging is associated with increased risk of major adverse cardiovascular events (MACE). LV GLS is associated with MACE in adults without prevalent cardiovascular disease (CVD). 2.38, p  = 0.04).

Cardiovascular Disease 40

Cardiovascular Disease Biomarkers Myocardial Infarction Heart Failure 40

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

The European Society of Cardiology (ESC) Congress 2024 (August 30 – September 2, 2024) has wrapped up, delivering groundbreaking insights into cardiovascular diseases and related conditions. REVERSE-FLOW Trial: Prof. Dr. Ingel Eitel (Germany) presented the randomized REVERSE-FLOW trial as Late Breaking Science.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

All About Cardiovascular System and Disorders

DECEMBER 15, 2023

CLEAR trial was a double blind, randomized, placebo controlled trial of patients who were unable or unwilling to take statins due to unacceptable adverse effects and had or were at high risk for cardiovascular disease. There was no increase in new onset diabetes mellitus or worsening of diabetes mellitus. There was 29.2

Cholesterol 52

Cholesterol Myocardial Infarction Cardiovascular Disease Diabetes 52

Cardiometabolic Health Congress

MARCH 8, 2024

Her research focuses on women’s cardiovascular health and cardio-obstetrics, cardiovascular risk prediction using coronary artery calcium scores and biomarkers, lipids, and cardiometabolic diseases.

Cardiac Rehabilitation 59

Cardiac Rehabilitation Academic Diabetes Research 59

Physiologically Speaking

APRIL 24, 2024

” ―William Shakespeare, Macbeth Sleep and cardiovascular disease: the epidemiological evidence Despite our knowledge that sleep is vital for human health and well being, we often neglect it. 7 8 [link] Short sleep duration may also affect biomarkers related to vascular function. More than one-third of U.S.

Blood Pressure 52

Blood Pressure Blood Clot COVID-19 Cardiovascular Disease 52

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Cardiovascular disease remains the leading cause of death worldwide , claiming 18 million lives annually. 42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Moreover, cardiovascular disease in women continues to be underrepresented and undertreated.

CME 103

CME Obesity Heart Failure Biomarkers 103

Dr. Malcolm Kendrick

OCTOBER 30, 2024

The hypothesis that a raised cholesterol level causes heart disease [atherosclerotic cardiovascular disease (ASCVD)] is possibly the single most powerful idea in medicine. Which remains the single most influential study on cardiovascular disease, ever. At least some of it. It was simply a matter of time.

Cholesterol 145

Cholesterol Article Research Diet 145